Pages that link to "Q37781747"
Jump to navigation
Jump to search
The following pages link to Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease (Q37781747):
Displaying 50 items.
- Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional study (Q21135215) (← links)
- Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk (Q26766528) (← links)
- Fibroblast Growth Factor Signaling in Metabolic Regulation (Q26772751) (← links)
- Endocrine FGFs: Evolution, Physiology, Pathophysiology, and Pharmacotherapy (Q26781556) (← links)
- The roles of fibroblast growth factors in the testicular development and tumor (Q26823032) (← links)
- Inventing new medicines: The FGF21 story (Q26823319) (← links)
- Pathophysiological roles of FGF signaling in the heart (Q26853186) (← links)
- Regulation and function of the FGF23/klotho endocrine pathways (Q26860470) (← links)
- Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders (Q27686803) (← links)
- Regulation of fibroblast growth factor 15/19 and 21 on metabolism: in the fed or fasted state (Q28070054) (← links)
- FGF21 requires βklotho to act in vivo (Q28485347) (← links)
- Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319 (Q28487909) (← links)
- Osteocyte-specific deletion of Fgfr1 suppresses FGF23 (Q28541582) (← links)
- Fundamentals of FGF19 & FGF21 action in vitro and in vivo (Q28729024) (← links)
- The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes (Q30234616) (← links)
- Metabolic role of fibroblast growth factor 21 in liver, adipose and nervous system tissues (Q33685319) (← links)
- Is fibroblast growth factor receptor 4 a suitable target of cancer therapy? (Q33751398) (← links)
- Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models (Q33985578) (← links)
- FGF-2 deficiency does not influence FGF ligand and receptor expression during development of the nigrostriatal system (Q34005504) (← links)
- The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract. (Q34219880) (← links)
- Roles of FGFs as Adipokines in Adipose Tissue Development, Remodeling, and Metabolism (Q34408855) (← links)
- The Fibroblast Growth Factor signaling pathway (Q34467171) (← links)
- Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease (Q34806589) (← links)
- Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease (Q35020888) (← links)
- Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes (Q35266374) (← links)
- Fibroblast growth factor 21: a novel metabolic regulator (Q35770027) (← links)
- Mapping the growth hormone--Stat5b--IGF-I transcriptional circuit (Q35854796) (← links)
- Signaling in cell differentiation and morphogenesis (Q36009264) (← links)
- Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats. (Q36486182) (← links)
- Feeding a Modified Fish Diet to Bottlenose Dolphins Leads to an Increase in Serum Adiponectin and Sphingolipids (Q36818730) (← links)
- Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial. (Q36856371) (← links)
- An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice (Q36886578) (← links)
- The role of Klotho in energy metabolism (Q36992839) (← links)
- Serum fibroblast growth factor 19 levels are decreased in Chinese subjects with impaired fasting glucose and inversely associated with fasting plasma glucose levels (Q37106431) (← links)
- Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements (Q37168681) (← links)
- Multiple faces of fibroblast growth factor-23 (Q37312020) (← links)
- Inhibition of FGF/FGFR autocrine signaling in mesothelioma with the FGF ligand trap, FP-1039/GSK3052230. (Q37457703) (← links)
- Vitamin D: calcium and bone homeostasis during evolution (Q37506713) (← links)
- REV-ERBα regulates Fgf21 expression in the liver via hepatic nuclear factor 6. (Q37612433) (← links)
- Elucidating fish oil-induced milk fat depression in dairy sheep: Milk somatic cell transcriptome analysis (Q37737986) (← links)
- Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy. (Q37849781) (← links)
- Control of asymmetric cell division of mammalian neural progenitors. (Q38004610) (← links)
- FGF, TGFβ and Wnt crosstalk: embryonic to in vitro cartilage development from mesenchymal stem cells (Q38098144) (← links)
- Progenitor genealogy in the developing cerebral cortex (Q38241685) (← links)
- Vitamin D: a dynamic molecule. How relevant might the dynamism for a vitamin be? (Q38591061) (← links)
- Effect of circulating glucagon and free fatty acids on hepatic FGF21 production in dairy cows (Q38631707) (← links)
- Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. (Q38633258) (← links)
- Towards the next generation of biomedicines by site-selective conjugation (Q38706553) (← links)
- FGF23 from bench to bedside. (Q38728860) (← links)
- Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus (Q38794405) (← links)